Approval · Notice of Compliance 27449 · 2022
ACH-MYCOPHENOLATE: Notice of Compliance 27449
Issued January 21, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27449
- Date
- January 21, 2022
- Company
- Accord Healthcare IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Updated product monograph and labelling materials.Administrative: Product Name Change
- Canadian reference product
- CELLCEPT
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACH-MYCOPHENOLATE | Not yet assigned | — |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 500 MG per TAB